The international meeting enabled close monitoring of the latest developments in NGS-based technologies.
Quilaban marked its presence, between 13th and 16th June, at the European Society of Human Genetics (ESHG). Considered one of the most important international meetings dedicated to human genetics, ESHG brought together specialists, researchers and leading companies in this field.
By attending the congress, Quilaban had the opportunity to closely follow the latest developments in Next-Generation Sequencing (NGS) based technologies. These technologies continue to transform the response capacity of laboratories, driving increasingly precise medicine.
Participation in ESHG proved important to identify trends, learn about new approaches and reinforce Quilaban’s mission to provide Portuguese laboratories with access to the most innovative market solutions.
By closely following the evolution of human genetics, Quilaban reinforces its commitment to continue bringing innovation closer to Portuguese laboratories and supporting the development of genetic diagnostics in Portugal.
